An observational study in Lung Cancer, Non-small Cell, sponsored by Latin American Cooperative Oncology Group. Completed at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-20.
Sponsored by Latin American Cooperative Oncology Group · Observational
RELANCE is a large multi-institutional study that aims to retrospectively collect information about diagnostic, treatment and outcome of patients diagnosed with locally advanced NSCLC in Brazil. It is hypothesized that there is a great heterogeneity in treatment patterns owing to inequities in access to adequate staging methods, optimal treatment and multidisciplinary teams in Brazil.
RELANCE study will collect sociodemographic and clinical data of patients diagnosed with locally advanced NSCLC in the period of January 2015 and Jun 2019 in the participating institutions. Socio-demographic characteristics, clinicopathological features, treatments patterns and outcomes will be recovered from medical charts. Disease status and survival data will be collected up to the last date of follow-up June 2021.
7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.
This study's enrollment of 403 is above the median of 189 across 1,514 observational studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →Latin American Cooperative Oncology Group is the lead sponsor of 46 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with stage IIIA or IIIB NSCLC in the period of January 2015 to December 2016.
Exclusion Criteria:
Overall survival
defined as time from diagnosis to death of any cause;
Time frame: Up to June 30, 2018
Progression free survival
defined as time from any line of treatment to progression of the disease or death of any cause
Time frame: Up to June 30, 2018
Time to next treatment
defined as time from start of the any treatment to the beginning of a second therapy
Time frame: Up to June 30, 2018
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Latin American Cooperative Oncology Group